AMANDA WILLS: Open Payments
NPI 1720526379 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,460 in 112 payments from 29 companies in 2025. Trend: 2023 $2,476 · 2024 $2,943 · 2025 $2,460
Food & beverage: $2,460
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $484 |
| Ascendis Pharma Endocrinology Inc | 7 | $236 |
| Lilly USA, LLC | 11 | $210 |
| Abbott Laboratories | 15 | $184 |
| Antares Pharma, Inc. | 7 | $167 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $133 |
| SANOFI-AVENTIS U.S. LLC | 5 | $105 |
| Amgen Inc. | 5 | $88 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $74 |
| IBSA Pharma Inc. | 3 | $73 |
Products named: Wegovy, Yorvipath, Ozempic, FREESTYLE LIBRE 3, XYOSTED, MOUNJARO, JARDIANCE, Kerendia.
Industry payments across NC — which companies pay providers there.
